Iv
Iveric (Astellas)
Parsippany NJFounded 2007200 employees
Private CapbiotechAcquiredOphthalmology
Platform: Izervay GA
Market Cap
N/A
All Drugs
4
Clinical Trials
6
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| IVE-1720 | IVE-1720 | Phase 2/3 | 2 | MALT1 | WilmsSCLC | ||
| IVE-1037 | IVE-1037 | Phase 2 | 1 | JAK2 | SLEObesity | ||
| IVE-3532 | IVE-3532 | Phase 1 | 1 | CDK2 | Hemophilia ARCC | ||
| IVE-9723 | IVE-9723 | Phase 3 | 2 | Tau | PNHIPF |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (3)